Immunic, Inc. (IMUX) will implement a 1-for-10 reverse stock split of its outstanding common shares, effective April 27, 2026.
The reverse split aims to help the company meet obligations under a securities purchase agreement signed with institutional and accredited investors on February 12, 2026.
In premarket trading, IMUX shares dropped 4.42% to $0.8602.
Deutsche EuroShop AG Releases 2025 Full-Year Financial ResultsHans-Peter Kneip, CEO, CFO, and Member of the Executive Board, presented Deutsche EuroShop…
New Chapter in Hawkins Saga Arrives April 23 The Stranger Things universe expands with 'Tales From '85,' an animated spin-off…
Early one morning, Tanisha Singh prepares a straightforward curry for her lunch while heading to work. Midway through, she discovers…
Analysts Flag Concerns Ahead of Robinhood Earnings ReportFinancial analysts are raising red flags about Robinhood Markets as the trading platform…
